Td Private Client Wealth LLC Summit Therapeutics Inc. Transaction History
Td Private Client Wealth LLC
- $4.07 Trillion
- Q2 2025
A detailed history of Td Private Client Wealth LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 74 shares of SMMT stock, worth $1,969. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74Holding current value
$1,969% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
239Shares Held
87.3MCall Options Held
1.77MPut Options Held
2.48M-
Baker Bros. Advisors LP New York, NY24.4MShares$650 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$310 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$210 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$175 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$129 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.35B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...